BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32875655)

  • 21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
    El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
    Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
    Warren LEG; Niman SM; Remolano MC; Landry JM; Nakhlis F; Bellon JR; Aizer AA; Lin NU; Tolaney SM; Regan MM; Overmoyer BA; Lynce F
    Cancer; 2022 Dec; 128(23):4085-4094. PubMed ID: 36210737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.
    Schairer C; Laurent CA; Moy LM; Gierach GL; Caporaso NE; Pfeiffer RM; Kushi LH
    Breast Cancer Res Treat; 2020 Sep; 183(2):467-478. PubMed ID: 32691376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?
    Lê MG; Arriagada R; Bahi J; Pfeiffer F; Cammoun M; Tabbane F; Rubino C
    Breast; 2006 Jun; 15(3):355-62. PubMed ID: 16198566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
    Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Pfeiffer RM; Gadalla SM; Swain SM; Merajver SD; Brown LM; Soliman AS
    Breast Cancer Res Treat; 2019 Jul; 176(2):407-417. PubMed ID: 31006821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory breast cancer: a single centre analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
    Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases.
    Hoffman HJ; Khan A; Ajmera KM; Zolfaghari L; Schenfeld JR; Levine PH
    Am J Clin Oncol; 2014 Aug; 37(4):315-21. PubMed ID: 23241503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
    Slaoui M; Zoure AA; Mouh FZ; Bensouda Y; El Mzibri M; Bakri Y; Amrani M
    BMC Cancer; 2018 Jul; 18(1):713. PubMed ID: 29976157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.
    Schairer C; Soliman AS; Omar S; Khaled H; Eissa S; Ayed FB; Khalafallah S; Ayoub WB; Kantor ED; Merajver S; Swain SM; Gail M; Brown LM
    Cancer Med; 2013 Apr; 2(2):178-84. PubMed ID: 23634285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
    Hussain MM; Ashley G; Daniel S; Sachin J; Amy K; Doreen A; Sasha B; Roman S; Ko Un P
    Clin Breast Cancer; 2023 Aug; 23(6):e354-e358. PubMed ID: 37301712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
    Nakhlis F; Regan MM; Chun YS; Dominici LS; Caterson S; Bellon JR; Warren L; Yeh ED; Jacene HA; King TA; Overmoyer B
    Breast J; 2020 Mar; 26(3):384-390. PubMed ID: 31448540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
    Jacene HA; DiPiro PJ; Bellon J; Hu J; Cheng SC; Warren L; Schlosnagle E; Nakhlis F; Rosenbluth JM; Yeh E; Overmoyer B
    Breast Cancer Res Treat; 2020 Jun; 181(2):383-390. PubMed ID: 32318957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
    Menta A; Fouad TM; Lucci A; Le-Petross H; Stauder MC; Woodward WA; Ueno NT; Lim B
    Surg Clin North Am; 2018 Aug; 98(4):787-800. PubMed ID: 30005774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.
    Kim MH; Lee S; Koo JS; Jung KH; Park IH; Jeong J; Kim SI; Park S; Park HS; Park BW; Kim JH; Sohn J
    PLoS One; 2015; 10(3):e0120320. PubMed ID: 25803816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive Subsets of Metastatic Triple Negative Breast Cancer.
    Singh J; Asad S; Zhang Y; Nock W; Adams E; Damicis A; Ramaswamy B; Williams N; Parsons HA; Adalsteinsson VA; Winer EP; Lin NU; Partridge AH; Overmoyer B; Stover DG
    Clin Breast Cancer; 2020 Feb; 20(1):e20-e26. PubMed ID: 31631016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.